Aruvant Announces Data Presentation on Lead Program ARU-1801 at European Hematology Association (EHA) 2021 Virtual Congress
/PRNewswire/ -- Aruvant Sciences ("Aruvant"), a private company focused on developing gene therapies for rare diseases, today announced the selection of an...
Source: prnewswire.com